A detailed history of Ergoteles LLC transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Ergoteles LLC holds 121,905 shares of HZNP stock, worth $0. This represents 20.67% of its overall portfolio holdings.

Number of Shares
121,905
Previous 96,905 25.8%
Holding current value
$0
Previous $9.97 Million 141413.03%
% of portfolio
20.67%
Previous 0.49%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $2.47 Million - $2.89 Million
25,000 Added 25.8%
121,905 $14.1 Billion
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $1.66 Million - $1.94 Million
-17,269 Reduced 15.13%
96,905 $9.97 Million
Q1 2023

May 10, 2023

BUY
$107.32 - $113.5 $3.23 Million - $3.42 Million
30,114 Added 35.82%
114,174 $12.5 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $3.78 Million - $6.9 Million
60,648 Added 259.05%
84,060 $9.57 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $1.38 Million - $1.98 Million
23,412 New
23,412 $1.45 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $647,983 - $949,613
-8,161 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $705,273 - $896,159
8,161 New
8,161 $859,000
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $4.28 Million - $5.14 Million
-46,562 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$86.24 - $95.92 $4.02 Million - $4.47 Million
46,562 New
46,562 $4.36 Million
Q4 2020

Feb 11, 2021

SELL
$67.0 - $84.39 $10.2 Million - $12.9 Million
-152,643 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $8.43 Million - $12.2 Million
152,643 New
152,643 $11.9 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.